Last week, several of the BioCommerce Week index companies reported their earnings for the quarter ended Dec. 31, 2004.

Highlights of selected companies’ financial reports follow.

Waters Sees 40-Percent
Growth in Mass Spec

Driven by a 40-percent growth in sales of its mass-spectrometry technology, Waters last week reported fourth-quarter sales of $324 million, up 18 percent over $275 million in sales for the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.